A Phase 3 Clinical Study of QL2106 Injection

Clinical trial NCT07511647 · RECRUITING

Trial details

NCT number: NCT07511647
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2026-06-15
Primary completion: 2027-12-30
Enrollment: 318

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.